In the Boardroom
Refine Search
Pharmaceutical
Respiratory disease specialist Verona Pharma has appointed Kenneth Newman to the newly-created chief medical officer position. 18 December 2014
Biotechnology
Genetic diagnostic lab, Claritas Genomics, has appointed Patrick Terry as chief commercial officer. 18 December 2014
Biotechnology
US biotech company Celgene Corp has made two appointments to its EMEA team. 18 December 2014
Pharmaceutical
French drugmaker Ipsen has appointed François Garnier as executive vice president, general counsel of the company. 17 December 2014
article
Late-stage gene therapy company, Spark Therapeutics, has appointed Rogerio Vivaldi as its first chief commercial officer. 16 December 2014
Biotechnology
US biotech major Gilead Sciences has appointed Philippe Bishop as senior vice president of hematology and oncology therapeutics. 15 December 2014
Pharmaceutical
US-Israeli company Immune Pharmaceuticals has appointed Daniel Kazado chairman of the board, succeeding Daniel Teper. 15 December 2014
Biotechnology
The co-founder of Dutch nanomedicine company Cristal Therapeutics, Joost Holthuis, has succeeded its founder Cristianne Rijcken as chief executive of the company. 15 December 2014
Biotechnology
Denmark-based biotech company Zealand Pharma announced today that senior vice president and chief business officer, Arvind Hundal, has stepped down to pursue other opportunities outside the company. 15 December 2014
Pharmaceutical
Ophthalmic specialist Santen has appointed Paolo Casati as general manager of Santen Italy, following the company’s launch in the region. 11 December 2014
Biotechnology
RNA therapy specialist RaNA Therapeutics has appointed Ronald Renaud as chief executive. 11 December 2014
Biotechnology
Biopharma commpany Ardelyx has appointed Jeremy Caldwell as executive vice president and chief scientific officer. 11 December 2014
Biotechnology
US biotech company Celgene has appointed Wim Souverijns as vice president general manager for the UK and Ireland. 11 December 2014
Biotechnology
Late-stage biopharma company Soligenix has appointed Oreola Donini as senior vice president and chief scientific officer. 10 December 2014
Pharmaceutical
Israel-based Teva Pharmaceuticals has appointed Yitzhak Peterburg as chairman of the board of directors. 27 November 2014
Pharmaceutical
PTC Therapeutics appoints Tuyen Ong senior vice president, head of clinical development and research
Pharma company PTC Therapeutics has appointed Tuyen Ong as senior vice president, head of clinical development and translational research. 27 November 2014
Pharmaceutical
Danish CNS specialist Lundbeck this morning announced the resignation of its chief executive, Ulf Wiinberg, with immediate effect. 24 November 2014
Pharmaceutical
The president of Japanese drug major Takeda Pharmaceutical’s (TYO: 4502) US subsidiary, Douglas Cole, has resigned, after 22 years with the company. 21 November 2014
Pharmaceutical
Belgian drug developer Ablynx has announced the appointment of Johan Heylen as chief commercial officer. 18 November 2014
Pharmaceutical
Ireland-headquartered generics major Actavis has appointed Maria Teresa (Tessa) Hilado as chief financial officer. 12 November 2014
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze